Wigmore Medical's innovation event heads to the Midlands

Wigmore Medical’s inaugural Innovation event held in London last month, brought together a curated selection of product innovations from across the global aesthetics market, giving practitioners the opportunity to explore emerging technologies, discover new products and consider how these could create opportunities within their own clinics.

Following the success of the London event, we’re looking forward to continuing those conversations with our practitioner colleagues in the Midlands on 8th December 2026.


Exploring the innovations shaping aesthetics
Wigmore’s Innovation event brought together 11 innovations spanning regenerative aesthetics, advanced skincare, body treatments and professional homecare. Each one had been selected to showcase developments shaping the industry, and highlight new possibilities for treatment, patient care and clinic growth.


Rather than simply introducing new products, the evening was designed to help practitioners understand how each innovation could work within their existing practice.


From enhancing current treatment pathways to introducing new categories, the focus is on identifying solutions that respond to patient needs, while creating meaningful commercial opportunities. Throughout the evening, attendees could meet the experts behind the products, ask questions, and at selected stations, see treatments in action. Our first event explored three key themes influencing the direction of aesthetic practice:


Regenerative aesthetics
The conversation around aesthetics is increasingly extending beyond volume, with growing interest in skin quality, collagen stimulation and supporting the skin’s own biological processes. PLENHYAGE XL and JULÄINE showcased two different approaches to this evolving area.


Advanced skincare
and professional homecare The connection between in-clinic treatments and at-home skincare continues to develop, with greater emphasis on sophisticated formulations, delivery systems nd evidence-informed approaches. LAB31B, The Skin Diary Pro-Helix C and HydroPeptide Syner-C+ demonstrated the ways that professional skincare can complement treatment programmes, and support ongoing patient care.


Evolving patient needs
As patient priorities change, clinics are continually looking for ways to adapt their treatment menus. Innovations addressing post-weight-loss skin including, Vol.U.Lift and Alidya, plus needle-free rejuvenation treatment Idenel, highlight how new technologies and approaches can help practitioners respond to a wider range of concerns.

I came all the way from Italy this evening to attend the Wigmore innovation evening, and am very excited to be here and part of Wigmore. Alidya is a CE marked injectable medical device, launched in Italy back in 2013. It is one of the only injectable devices approved in over 70 countries to treat cellulite. Cellulite has often been approached topically in the past, but with Alidya we are treating cellulite from within, which makes it unique as a standalone treatment.
Matteo Fabbri, Export & Business Development at Marllor Biomedical

Join us in the Midlands
Following the enthusiasm and inspiring conversations sparked by our first event, we’re delighted to bring the experience to the Midlands, with an exciting new addition to the programme: Teoxane’s Teosyal Skin Booster.

Discover the latest developments in aesthetics, connect with industry experts and peers, and explore practical ways to bring new ideas and innovations into your clinic. There will also be exclusive event-only deals on the evening for attendees.

Discover what’s new, ask the questions that matter to your practice, and explore the innovations that could help shape your business:

• Alidya
• HydroPeptide-Syner C
• Idenel Glassifier
• Lab31B
• Plenhyage
• The Skin Diary-Pro Helix C
• Subderma
• Vol.U.Lift Body
• RevitaLash
• AQ Skin Solutions
• Teoxane Teosyal Skin Booster